Press releases
November 11, 2026
Participants Reporting Frequent Hunger Fall From 49% to 6% in Four-Week Trilogiii Satiety Study
More than 8 in 10 participants said their hunger, cravings and "food noise" improved while following a plan of smaller or fewer meals.
About Triii Therapeutics
Intelligently Designed Three-Phase Health Solutions™
Triii Therapeutics™ is a Castle Rock, Colorado-based dietary supplement company and the maker of Trilogiii™. The company focuses on products for the body's intelligently designed three-in-one or three-phase biological systems.
About Paul R. Myhill, founder and lead researcher
Paul R. Myhill is a named inventor on seven U.S. patents and multiple international patents, with almost 25 years of work in nutraceuticals, primarily nutrigenomics and epigenetics. Companies he founded have generated more than $3 billion in cumulative revenue, and his formulations have been featured in nearly 50 peer-reviewed studies. Earlier in his career, he consulted for clinical dietary programs at major U.S. research hospitals.
